Evidence map›Paper›PMID 27993970›Full record

ArticleThe Biochemical journal2017

Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.

Kirsty F Houslay, Frank Christian, Ruth MacLeod, David R Adams, Miles D Houslay, George S Baillie

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. PDE4-Mediated cAMP Signalling.Journal of cardiovascular development and disease · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kirsty F HouslayInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
Frank ChristianInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
Ruth MacLeodInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K.
David R AdamsInstitute of Chemical Sciences, Heriott-Watt University, Edinburgh, U.K.
Miles D HouslayMironid Ltd, BioCity Scotland, Bo'Ness Road, Newhouse, North Lanarkshire ML1 5UH, U.K.
George S BaillieInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, U.K. george.baillie@glasgow.ac.uk.
University of Glasgow · GBKing's College London · GBNHS Lanarkshire · GB

Funding

Medical Research Council MR/J007412/1
6 · The paper itself

Abstract

Cyclic AMP (cAMP)-specific phosphodiesterase-4 (PDE4) enzymes underpin compartmentalised cAMP signalling by localising to distinct signalling complexes. PDE4 long isoforms can be phosphorylated by mitogen-activated protein kinase-activated protein kinase 2 (MK2), which attenuates activation of such enzymes through their phosphorylation by protein kinase A. Here we show that MK2 interacts directly with PDE4 long isoforms and define the sites of interaction. One is a unique site that locates within the regulatory upstream conserved region 1 (UCR1) domain and contains a core Phe141, Leu142 and Tyr143 (FLY) cluster (PDE4A5 numbering). Located with the second site is a critical core Phe693, Glu694, Phe695 (FQF) motif that is also employed in the sequestering of PDE4 long forms by an array of other signalling proteins, including the signalling scaffold β-arrestin, the tyrosyl kinase Lyn, the SUMOylation E2 ligase UBC9, the dynein regulator Lis1 (PAFAH1B1) and the protein kinase Erk. We propose that the FQF motif lies at the heart of a multifunctional docking (MFD) site located within the PDE4 catalytic unit. It is clear from our data that, as well as aiding fidelity of interaction, the MFD site confers exclusivity of binding between PDE4 and a single specific partner protein from the cohort of signalling proteins whose interaction with PDE4 involves the FQF motif.

Indexed as

Catalytic DomainMolecular Docking Simulation1-Alkyl-2-acetylglycerophosphocholine EsteraseAmino Acid MotifsAnimalsbeta-ArrestinsChlorocebus aethiopsCOS CellsCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4Gene ExpressionHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2Microtubule-Associated Proteins1-Alkyl-2-acetylglycerophosphocholine Esterasebeta-ArrestinsCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4Intracellular Signaling Peptides and Proteinslyn protein-tyrosine kinaseMAPK1 protein, humanMAP-Kinase-Activated Kinase 2Microtubule-Associated ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PAFAH1B1 protein, humanPDE4A protein, humanProtein Serine-Threonine KinasesRecombinant Proteinssrc-Family KinasesUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9cAMPcyclic nucleotide phosphodiesterasesprotein–protein interactions

Identifiers

PMID27993970
PMCPMC5290487
OpenAlexW2562503140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.